We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTOO
1676
DELISTED
T2 Biosystems, Inc
TTOO
– –
-1
Closed -$10K
KAMN
1677
DELISTED
Kaman Corp
KAMN
– –
-20,135
Closed -$1.2M
CPE
1678
DELISTED
Callon Petroleum Company
CPE
– –
-256,576
Closed -$11.1M
PGTI
1679
DELISTED
PGT, Inc.
PGTI
– –
-101,295
Closed -$1.75M
CBAY
1680
DELISTED
Cymabay Therapeutics
CBAY
– –
-8,726
Closed -$45K
TGH
1681
DELISTED
Textainer Group Holdings limited
TGH
– –
-10,622
Closed -$105K
AAIC
1682
DELISTED
Arlington Asset Investment Corp.
AAIC
– –
-10,944
Closed -$60K
HEP
1683
DELISTED
Holly Energy Partners, L.P.
HEP
– –
-51,010
Closed -$1.29M
USDP
1684
DELISTED
USD PARTNERS LP
USDP
– –
-800
Closed -$8K
TRHC
1685
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
– –
-104,321
Closed -$5.73M
CIR
1686
DELISTED
CIRCOR International, Inc
CIR
– –
-18,753
Closed -$704K
SYNH
1687
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-5,148
Closed -$274K
MMP
1688
DELISTED
Magellan Midstream Partners, L.P.
MMP
– –
-400
Closed -$27K
WWE
1689
DELISTED
World Wrestling Entertainment
WWE
– –
-27,983
Closed -$1.99M
NUVA
1690
DELISTED
NuVasive, Inc.
NUVA
– –
-2,943
Closed -$187K
AMRS
1691
DELISTED
Amyris Inc.
AMRS
– –
-2,981
Closed -$14K
USX
1692
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
– –
-6,648
Closed -$32K
STSA
1693
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
– –
-33,380
Closed -$501K
KBAL
1694
DELISTED
Kimball International
KBAL
– –
-759
Closed -$15K
FRC
1695
DELISTED
First Republic Bank
FRC
– –
-1,899
Closed -$184K
PRVB
1696
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-200,314
Closed -$1.37M
AUY
1697
DELISTED
Yamana Gold, Inc.
AUY
– –
-17,000
Closed -$54K
ATCO
1698
DELISTED
Atlas Corp.
ATCO
– –
-9,902
Closed -$105K
MYOV
1699
DELISTED
Myovant Sciences Ltd.
MYOV
– –
-49,857
Closed -$259K
AVYA
1700
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
– –
-449,502
Closed -$4.6M
66 67
68
69 70

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.